Actemra actpen 162 MG/0.9 ML 0.9ML
Ended Awarded Last action
- Contract number
- SPE2DR26F4F3V
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $85,856
Award facts
- Contract value 100% obligated
- $85,856.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $85,856 by the Defense Logistics Agency on January 21, 2026, for the supply of Actemra Actpen 162 mg/0.9 mL auto-injector pens. This firm fixed-price, non-set-aside contract will be fulfilled from the company's facility in Conshohocken, Pennsylvania, with a completion date of January 22, 2026. The delivery order represents a task order issued under Amerisourcebergen's existing Indefinite Delivery Contract with DLA Troop Support Medical, a $999,999,999 comprehensive pharmaceutical supply vehicle that extends through December 2026 and supports military healthcare programs globally.
Actemra (tocilizumab) is a biologic medication primarily used to treat rheumatoid arthritis and other inflammatory conditions within military and veteran healthcare systems. The DLA Troop Support Medical contract vehicle enables efficient procurement of a broad spectrum of pharmaceutical products, including specialty medications, brand-name and generic drugs, and medical supplies, serving the Defense Health Agency, U.S. Coast Guard, and other federal healthcare entities. Amerisourcebergen's selection reflects its proven capability to meet federal procurement requirements through open competition and its extensive experience as a critical vendor in the federal medical supply chain.
Quick answers
Who was awarded contract SPE2DR26F4F3V?
SPE2DR26F4F3V was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DR26F4F3V worth?
The government has obligated $85,856 on SPE2DR26F4F3V.
Is contract SPE2DR26F4F3V an order under another contract?
Yes. SPE2DR26F4F3V is a delivery order under SPE2DR25D3012, an indefinite delivery contract.
Was contract SPE2DR26F4F3V competed?
The extent of competition for SPE2DR26F4F3V was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award